January 10, 2008 — Most patients found to have a small kidney tumor, between 2 and 4 cm in size, have the whole kidney removed. However, new findings suggest that for younger patients a partial ...

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of end-stage renal failure, characterised by progressive cyst formation that distorts renal architecture and ...

The decision to undergo partial instead of radical nephrectomy should be individualized, according to investigators. In patients with localized renal cell carcinoma (RCC), nephron-sparing partial ...

Please provide your email address to receive an email when new articles are posted on . Nephrectomy can be effectively performed in patients with autosomal dominant PKD for various indications, such ...

New study findings “are critically important in patient counseling and surgical planning, particularly for patients with risk factors for renal deterioration,” according to investigators. A lower ...

Please provide your email address to receive an email when new articles are posted on . Findings showed no significant differences in surgical outcomes among age groups. Mortality rates were highest ...

AUSTIN, Texas -- Cytoreductive nephrectomy improved overall survival (OS) by more than a year for patients with metastatic renal cell carcinoma (mRCC) with sarcomatoid or rhabdoid (S/R) ...

Prediction of response to sunitinib in patients with advanced renal cell carcinoma (RCC) using mass spectrometry-based (phospho) proteomics. This is an ASCO Meeting Abstract from the 2021 ASCO Annual ...

Robotic-assisted partial nephrectomy (RAPN) led to a lower rate of complications compared with open partial nephrectomy (OPN) in patients with intermediate- or high-complexity kidney tumors, the ...

Systematic review and REMARK scoring of renal cell carcinoma (RCC) prognostic circulating biomarker manuscripts. This is an ASCO Meeting Abstract from the 2019 Genitourinary Cancers Symposium. This ...

The 2026 ASCO annual meeting featured an oral abstract kidney cancer session and a presentation by Dr. Toni Choueiri discussing a ctDNA analysis in participants with renal cell carcinoma (RCC) treated ...